Steven G. Coca

Dr. Steven G. Coca is a graduate of the University of New England College of Osteopathic Medicine. He completed his medical residency and clinical nephrology fellowship at Yale University and Yale-New Haven Hospital in Connecticut. He also received a Master’s Degree in Epidemiology and Public Health during his training at Yale, later serving as an Assistant Professor in the Section of Nephrology until his recruitment to Mount Sinai in 2014 as Associate Professor. Currently, Dr. Coca is the Director for Clinical Research for the Division of Nephrology and is the Associate Chair for Clinical and Translational Research for the Department of Medicine at the Icahn School of Medicine at Mount Sinai.

Dr. Coca’s research has focused on using novel biomarkers to improve risk stratification in patients with acute kidney injury and patients at risk or with prevalent chronic kidney disease. He has been continually funded by the NIH over the last decade for multiple biomarker-related projects. He is the co-founder of RenalytixAI.